학술논문
Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR)
Document Type
article
Author
Hiroshi Tanaka; Hiroyuki Suzuki; Junichi Shimizu; Daichi Fujimoto; Toshiyuki Kozuki; Osamu Hataji; Kyoichi Okishio; Ryo Morita; Haruhiro Saito; Hiroshi Sakai; Young Hak Kim; Makiko Yomota; Makoto Nishio; Keisuke Aoe; Osamu Kanai; Toru Kumagai; Kayoko Kibata; Hiroaki Tsukamoto; Satoshi Oizumi; Keiko Mizuno; Takeshi Masuda; Takashi Haku; Isamu Okamoto; Hirotoshi Hoshiyama; Nobumichi Yada; Yuichiro Ohe
Source
ESMO Open, Vol 5, Iss 4 (2020)
Subject
Language
English
ISSN
2059-7029
Abstract
Objectives We conducted a subanalysis of data from the multicentre, retrospective observational Nivolumab Japan Real World (CA209-9CR) study to evaluate nivolumab effectiveness and safety in elderly patients (aged ≥75 years) with advanced/metastatic non-small cell lung cancer.Materials and methods Medical record data of patients initiating nivolumab treatment between April 2016 and December 2016 were collected using electronic data capture from 23 cancer hospitals in Japan between March 2017 and August 2018. Nivolumab treatment data were collected to investigate the treatment patterns by age group (